Search

Your search keyword '"McAdoo, Stephen"' showing total 538 results

Search Constraints

Start Over You searched for: Author "McAdoo, Stephen" Remove constraint Author: "McAdoo, Stephen"
538 results on '"McAdoo, Stephen"'

Search Results

2. Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial

4. The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial

5. Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort

6. Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial

7. Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group

8. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort

10. The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and Trials

11. Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy

15. Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients

16. Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study

18. Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence

20. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection

22. Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era

23. Collagen IVα345 dysfunction in glomerular basement membrane diseases. I. Discovery of a COL4A3 variant in familial Goodpasture’s and Alport diseases

24. 2020 international consensus on ANCA testing beyond systemic vasculitis

28. #3076 A UK parallel cohort study on renal ANCA associated vasculitis outcomes for avacopan exposed and matched unexposed cohorts

29. #3108 Rituximab in adult-onset IgA vasculitis

30. Description and cross-sectional analyses of 25,880 adults and children in the UK National Registry of Rare Kidney Diseases cohort

31. Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial

32. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort

34. Large-vessel vasculitis

39. Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group

40. The role of ANCA in the management of cocaine‐induced midline destructive lesions or ENT pseudo‐granulomatosis with polyangiitis: a London multicentre case series.

41. The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and Trials

42. The role of ANCA in the management of cocaine‐induced midline destructive lesions or ENT pseudo‐granulomatosis with polyangiitis: a London multicentre case series

43. The role of spleen tyrosine kinase in glomerulonephritis

50. Traditional and Disease Specific Risk Factors for Cardiovascular Events in ANCA-Associated Vasculitis: A Multinational Retrospective Study

Catalog

Books, media, physical & digital resources